MedTrace Logo

Reducing Perioperative S. Aureus Transmission Via OR PathTrac

NCT04657185 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 804

Last updated 2025-09-11

No results posted yet for this study

Summary

Healthcare-associated infections (HAIs) occur frequently and are associated with patient harm. It is important that healthcare facilities take the necessary steps to prevent the spread of resistant bacteria. ESKAPE bacteria (Enterococcus, S. aureus, Klebsiella, Acinetobacter, Pseudomonas, and Enterobacter spp.) are particularly pathogenic. Isolation of these pathogens from intraoperative reservoirs has been associated with postoperative infection development (i.e. surgical site infections). This project involves implementation of a software platform and bacterial collection system (OR PathTrac) that leverages the epidemiology of intraoperative bacterial transmission to guide dynamic, prospective improvements in perioperative infection control measures. The investigators will assess the effectiveness of OR PathTrac feedback in optimizing an evidence-based, multifaceted, perioperative infection control program.

Conditions

  • S. Aureus Transmission
  • Surgical Site Infection

Interventions

OTHER

OR PathTrac Feedback Optimization

OR PathTrac (RDB Bioinformatics, Omaha, NE 68154) uses a systematic phenotypic approach leveraging temporal association to monitor 13 anesthesia work area reservoirs proven to be associated with high-risk intraoperative bacterial transmission events and subsequent infection development.

Sponsors & Collaborators

  • RDB Bioinformatics

    collaborator INDUSTRY

  • University of Iowa

    collaborator OTHER

  • Trustees of Dartmouth College

    collaborator OTHER

  • Georgetown University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-15
Primary Completion
2020-03-20
Completion
2020-03-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04657185 on ClinicalTrials.gov